A research letter in JAMA Internal Medicine discusses trends in Medicare spending for care at the end-of-life.
Read More
A study in Health Affairs looks at the potential value of one precision medicine.
Its not really shocking, but depressingly expected for drug companies to screw the public by preventing competition.
Another Milliman-related post, this time for their annual cost of health insurance report, which shows ongoing growth.
America’s Health Insurance Plans release a study conducted by Milliman showing where commercial health insurance dollars go.
New “precision” medicines are being approved with fewer and small trials, which may raise safety questions.
A paper from the NBER discusses the lifetime out-of-pocket medical expenses households with persons over 70 face.
A brief from AHRQ summarizing research on mobile apps for diabetes management finds little value in improving health.
A study in Health Affairs finds small benefit from public health expenditures.
Today we look at a recent paper that once again correlates hospital market power and prices, a major cause of excessive health spending.
Today’s price post discusses another KFF/Peterson work which analyzes prices and utilization across countries.
It is health care price week, and we start off with a Peterson/Kaiser Health System Tracker piece on price trends over the last few decades.
An organization called Consumers for Quality Care releases a survey of American’s views on the health system.
Surescripts releases its annual report on the state of electronic transaction use in drug prescribing.
Research in the Journal of Health Economics examines health spending as people age.
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.